http://www.bbc.com/news/business-35090087
An Australian court has ordered products in the Nurofen pain relief range off the shelves, saying the UK-based manufacturer misled consumers.
It said products marketed to treat specific pains, such as migraines, were identical to its standard Nurofen product despite being priced higher.
The products affected by the order include Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain and Nurofen Tension Headache.
The retail price for each of the pain-specific products was also found to be "significantly higher than that of other comparable analgesic products which also act as general pain relievers," the Australian Competition and Consumer Commission (ACC) said.
The watchdog said the court had found each product "was formulated to treat a particular type of pain; and solely or specifically treated a particular type of pain" - but that each product contained the same active ingredient, ibuprofen lysine 342mg.
However the products were found to be "no more effective at treating the type of pain described on its packaging than any of the other Nurofen specific pain products."
